Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 13, Issue 12
|
pp. 16541–16566
Insights of fibroblast growth factor receptor 3 aberrations in pan-cancer and their roles in potential clinical treatment
Back to article
Figure 7
(7 of 8)
−
100%
+
Figure 7.
Pan-cancer analysis of FGFR3 alterations and distribution.
(
A
) The alteration (mutation and CNVs) frequency of FGFR3 across various tumor types. (
B
) The distribution of CNV cases along with mutations located in protein functional domains.
